Clinical research of a second transurethral resection for non muscle-invasive bladder cancer
He Quanfang1, Tang Hua2
1Fujian University of Traditional Chinese Medicine, Fuzhou 350000, China; 2Department of Urology, Second Hospital of Sanming, Affiliated Fujian University of Traditional Chinese Medicine
Abstract：Objective: To investigate the effect of repeat transurethral resection for non muscle-invasive bladder cancer. Methods: All 62 cases of non muscle-invasive bladder cancer were divided into 2 groups: 30 in experimental group treated with second resection after the first transurethral resection 4 weeks later; the control group (n=32) given single transurethral resection of bladder tumor (TURBT) in the same period. All patients were treated with pirarubicin bladder irrigation after the TURBT in the two groups. Tumor recurrence rate and progression rate were observed. Results: Tumor recurred in 8 patients in the experimental group and 19 in the control group during the follow-up period of two years. There was a significant reduction in the recurrence rate in the experimental grooup compared with the control group. There was no significant difference in progression rate between the two group (10% vs. 21.9%, P>0.05). Conclusions: Second transurethral resection reduces the recurrence rate, but did not reduce the risk of tumor progression in non muscle-invasive bladder cancer.
何泉芳,唐华. 二次电切治疗非肌层浸润性膀胱癌的临床研究[J]. 微创泌尿外科杂志, 2015, 4(5): 289-291.
He Quanfang, Tang Hua. Clinical research of a second transurethral resection for non muscle-invasive bladder cancer. JOURNAL OF MINIMALLY INVASIVE UROLOGY, 2015, 4(5): 289-291.
[1]吴建华. 经尿道膀胱肿瘤电切治疗浅表性膀胱癌疗效观察.中华医院感染学杂志,2011,21(18): 3856-3858. [2]Sfakianos JP, Kim PH, Hakimi AA,et al. The effect of restaging transurethral resection on recurrence and progression rates in patients with nonmuscle invasive bladder cancer treated with intravesical bacillus Calmette-Guerin. J Urol, 2014,191(2): 341-345. [3]Ali MH, Ismail IY, Eltobgy A, et al. Evaluation of second-look transurethral resection in restaging of patients with nonmuscle-invasive bladder cancer. J Endourol, 2010,24(12): 2047-2050. [4]Divrik RT, Yildirim U, Zorlu F, et al. The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial. J Urol, 2006,175(5): 1641-1644. [5]Dobruch J, Borowka A, Herr HW. Clinical value of transurethral second resection of bladder tumor: systematic review. Urology, 2014,84(4): 881-885. [6]Verne J, Turner W, Huddart R, et al. Bladder Cancer: Diagnosis and Management. London: National Institute for Health and Care Excellence (UK), 2015:139-203. [7]那彦群,叶章群,孙光,等.中国泌尿外科疾病诊断治疗指南(2014版).北京:人民卫生出版社,2014:28.
